Skip to content
OpenCapital
Get started

McKesson MCK EPS (Diluted)

EPS (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
$8.26+170%
Cencora logo
CencoraCOR
$8.40+128%
AbbVie logo
AbbVieABBV
$0.39-45.8%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0.19+375%
Viatris logo
ViatrisVTRS
$0.15+106%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
-$0.02+90.5%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$89.43B-0.8%
Enterprise value$87.73B-5.7%
P/E18.8×-8.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's EPS (diluted)?
McKesson (MCK) reported EPS (diluted) of $13.65 in Q1 2026.
How has McKesson's EPS (diluted) changed year-over-year?
McKesson's EPS (diluted) increased by 37.6% year-over-year, from $9.92 to $13.65.
What is the long-term trend for McKesson's EPS (diluted)?
Over 4 years (2022 to 2026), McKesson's EPS (diluted) has grown at a 52.1% compound annual growth rate (CAGR), from $7.18 to $38.41.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.